Collegium Pharmaceutical (COLL) EBT Margin (2016 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly EBT Margin of 9.68% for Q1 2026, up 793.0% year-over-year from 1.08% in Q1 2025, and down 31.48% quarter-over-quarter from 14.13% in Q4 2025.
Collegium Pharmaceutical (COLL) EBT Margin (2016 - 2026) Analysis & Trends
Collegium Pharmaceutical's EBT Margin history runs 11 years deep, the most recent figure standing at 9.68% for Q1 2026.
- In Q1 2026, EBT Margin rose 793.0% year-over-year to 9.68%; the TTM figure through Mar 2026 stood at 13.59% (up 107.0% YoY), while the FY2025 annual figure was 11.87%, down 374.0% from the prior year.
- EBT Margin for Q1 2026 stood at 9.68%, down from 14.13% in the prior quarter.
- The five-year high for EBT Margin was 46.37% in Q4 2024, with the low at 18.92% in Q1 2022.
- The 5-year median for EBT Margin is 9.78% (2024), against an average of 10.67%.
- Peak annual rise in EBT Margin reached 9589 bps in 2022, while the deepest fall reached 3656 bps in 2022.
- Collegium Pharmaceutical's EBT Margin stood at 5.54% in 2022, then surged by 663 bps to 31.19% in 2023, then surged by 49 bps to 46.37% in 2024, then plunged by 70 bps to 14.13% in 2025, then slumped by 31 bps to 9.68% in 2026.
- Business Quant data shows COLL's EBT Margin at 9.68% in Q1 2026, 14.13% in Q4 2025, and 20.75% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Collegium Pharmaceutical | 889.49 Mn | 740.17 Mn | 110.29 Mn | -6.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -104.82% |
| Mar 31, 2026 | 9.68% |
| Dec 31, 2025 | 14.13% |
| Sep 30, 2025 | 20.75% |
| Jun 30, 2025 | 9.06% |
| Mar 31, 2025 | 1.76% |
| Dec 31, 2024 | 46.37% |
| Sep 30, 2024 | 9.78% |
| Jun 30, 2024 | 20.03% |
| Mar 31, 2024 | 25.27% |
| Dec 31, 2023 | 31.19% |
| Sep 30, 2023 | 21.05% |
| Jun 30, 2023 | 13.13% |
| Mar 31, 2023 | -12.13% |
| Dec 31, 2022 | -5.54% |
| Sep 30, 2022 | 1.13% |
| Jun 30, 2022 | -5.38% |
| Mar 31, 2022 | -18.92% |
| Dec 31, 2021 | -101.43% |
| Sep 30, 2021 | 11.46% |